Vensana Capital® Portfolio News
Category: Vensana Capital® Portfolio News
Vensana Capital® Portfolio News
Evident Vascular Exits Stealth with $35 Million Series A Funding to Develop Vascular Imaging Platform
Vensana Capital® Portfolio News
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Vensana Capital® Portfolio News
SpyGlass Pharma Completes $90 Million Series C Financing to Advance Novel Treatments for Glaucoma and other Chronic Ophthalmic Diseases
Vensana Capital® Portfolio News
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Vensana Capital® Portfolio News
